/templatefiles/umc_video.aspx?id=2147548944Mannings for Healthhttps://www.youtube.com/watch?v=Vtwv1P4y76U2016-04-25-01 $100 campaign for Children’s of Mississippi growth starts with $10 million gift from Sandersons
  • Kenneth "Ken" R. Butler, PhD

    butler, kenneth.pngAssociate Professor-Nonclinical
    Phone: (601) 984-4939
    Fax: (601) 815-3422  


    • BS - University of Mississippi
    • MS - University of Mississippi
    • PhD - University of Mississippi


    Dr. Butler is an associate professor of medicine and serves as project administrator and study publications coordinator on the Atherosclerosis Risk in Communities (ARIC) Study and co-investigator on the Jackson Heart Study (JHS). 

    Dr. Butler completed his graduate training in Clinical Health Sciences at UMMC in 2001. He is a fellow of the American Heart Association and member of the American Society of Hypertension. Over the past 11 years, he has served on multiple ARIC and JHS committees and subcommittees. Dr. Butler has authored or co-authored a significant number of peer-reviewed articles in the field of epidemiology and prevention.  He is also active in a number of state, regional, and national conferences where he and students, residents or fellows he's mentored have presented important findings.

    While at UMMC, Dr. Butler has worked on various clinical and epidemiological studies examining the cardiovascular disease (CVD) burden and risk factors in vulnerable Mississippi populations. Dr. Butler's primary research interests include inflammation, hypertension, and imaging.  Both cardiovascular disease and neurocognitive decline share similar risk factors. His research focuses on how modifiable risk factors, particularly hypertension and inflammation, may influence these disease states. Both risk factors have been implicated in neuronal loss resulting in neurocognitive decline as well as contributing to cardiovascular disease over time. Dr. Butler's ultimate goal is to further explain how inflammatory pathways contribute to neurological and vascular loss of function and identify possible mechanisms through which these pathways may be inhibited.

    Dr. Butler also speaks to groups of graduate students, residents and fellows regarding epidemiology, prevention and laboratory biomarkers. He also uses every opportunity to speak to lay audiences about managing risk factors for CVD and has spoken to numerous foreign medical delegates interested in developing disease surveillance programs in their home countries.